Community pharmacy contractors are reminded of the requirement to submit New Medicine Service (NMS) summary data to the NHS Business Services Authority (NHSBSA) within 10 working days from the last day of September 2022. Further information on the process to follow to submit NMS quarterly information can be found on the NHSBSA website. The
Read moreCommunity pharmacy contractors are reminded of the requirement to submit New Medicine Service (NMS) summary data to the NHS Business Services Authority (NHSBSA) within 10 working days from the last day of September 2022. Further information on the process to follow to submit NMS quarterly information can be found on the NHSBSA website. The
Read morePSNC is progressing work to enhance its negotiating capacity, strengthen its governance, develop a new vision and strategy for the sector, and more, in line with the Transforming Pharmacy Representation (TAPR) work programme. At its meeting in September, PSNC Members considered and voted on changes to the PSNC Constitution and to reduce the Committee size,
Read moreThe Department of Health and Social Care (DHSC) has today (03/10/2022) granted the following list of price concessions for September 2022: Drug Pack size Price concession Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream 30 £100.12 Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g ointment 30 £100.12 Liothyronine 5microgram tablets 28 £100.94 Sodium fusidate
Read moreCommunity pharmacy contractors who use NHS Profile Manager to update their pharmacy information are being invited by NHS Digital to test new service designs for the tool via a short 45-minute testing session. The testing sessions will be held via Microsoft Teams during the week commencing 10th October 2022. The sessions will be interactive, so
Read moreFollowing applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 14 new products will be classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 October 2022. This takes the total number of products granted DND status over the past
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Dioralyte® oral rehydration sachets. MSN/2022/082 Tier 2 – medium impact Date of issue 30th September 2022 Dioralyte® oral rehydration sachets are expected to be in limited supply until late December 2022. Limited stock of Dioralyte® Relief oral powder sachets remain available
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Nafarelin (Synarel®) 200microgram/dose nasal spray. MSN/2022/081 Tier 2 – medium impact Date of issue 30th September 2022 Nafarelin (Synarel®) 200microgram/dose nasal spray is out of stock until late-December 2022. Buserelin (Suprecur®) nasal 150microgram/dose spray is out of stock until late-December 2022
Read moreFollowing the announcement of the CPCF arrangements for 2022/23 and 2023/24, this follow up lays out some of the changes to margin delivery and fees, which will be enacted over the second half of 2022/23 and going into 2023/24. A summary of the main changes contractors will experience is: Margin delivery rates will increase from
Read moreThe Department of Health and Social Care (DHSC) has today (30/09/2022) granted the following list of price concessions: Drug Pack size Price concession Aripiprazole 10mg tablets 28 £78.00 Aripiprazole 15mg tablets 28 £45.00 Aripiprazole 1mg/ml oral solution 150 £105.87 Aripiprazole 5mg tablets 28 £37.55 Baclofen 5mg/5ml oral solution sugar free 300 £3.91 Citalopram 10mg tablets
Read more
